24-Hour Picks Entry: close of 2026-09-10 — Exit: close of 2026-09-14
| Ticker | Company | Rationale | Conf | Entry | Exit | Peak | Return |
|---|---|---|---|---|---|---|---|
| LONG SRPT Entered $21.11 | Sarepta Therapeutics | FDA PDUFA date Monday 9/14 for SRP-9001 gene therapy (Duchenne muscular dystrophy). Friday close $48.20 at 20-day SMA support with 1.8M volume. Binary catalyst: approval would gap to $60s, CRL drops to $30s. Risk-defined long with tight stop below $46.50. | 8 | $21.11 | $20.92 | $21.40 | ▼ -0.90% |
| LONG PLUG Entered $2.04 | Plug Power Inc | Hydrogen sector momentum + Monday 8:30 AM Empire State Mfg Index (est -5.0 vs -8.2 prior) could boost clean energy. Friday close $12.45 holding 50-day SMA, 15M volume. DOE loan office decision expected this week. Entry on 15-min break above $12.60 VWAP. | 7 | $2.04 | $2.06 | $2.15 | ▲ +0.98% |
| SHORT ROOT Entered $54.84 | Root Inc | Friday 18% gap-up on no news to $28.50, RSI 78, 3x avg volume. Exhaustion candle at 200-day resistance ($29.20). No Monday catalyst; insider lockup expiry 9/15. Short near $28.80 with stop above $30. Target $25.50 (Friday VWAP). | 8 | $54.84 | $54.33 | $51.88 | ▲ +0.93% |
| LONG SOFI Entered $17.29 | SoFi Technologies | Analyst upgrade weekend (Morgan Stanley to Overweight, PT $18). Friday close $13.80 at 20-day breakout, 22M volume. Student loan refi tailwind + Monday consumer credit data (3 PM ET). Buy pullback to $13.60-$13.70 zone. | 7 | $17.29 | $17.65 | $17.75 | ▲ +2.08% |
24-Hour Picks Entry: close of 2026-09-10 — Exit: close of 2026-09-14
| Ticker | Company | Rationale | Conf | Entry | Exit | Peak | Return |
|---|---|---|---|---|---|---|---|
| LONG CRBP Skipped | Corbus Pharmaceuticals Holdings Inc | Catalyst: CANYON-1 Phase 1b topline data conference call Monday 8:00 AM EDT (pre-market) for CRB-913 obesity candidate. Binary event - positive weight loss data could trigger major gap up in this sub-$5 biotech. Peripherally restricted CB1 inverse agonist offers differentiation vs GLP-1s. 240-patient dose-ranging study design (20/40/60mg) with 12-week treatment. High short interest historically adds squeeze potential. Watch premarket volume for confirmation. | 8 | $8.24 | $8.08 | $8.70 | ▼ -1.94% |
| LONG NRXP Entered $3.40 | NRx Pharmaceuticals Inc | Multiple converging catalysts: 1) FDA-cleared Zeta TMS Robotic System deployment at HOPE Therapeutics subsidiary (training underway, Florida launch imminent), 2) Preservative-free ketamine ANDA - FDA completed first-cycle review Aug 7 with no drug-related major deficiencies, 3) DARPA prime contractor for SPARC-TMS Phase 2/3 trial ($11.5M+), 4) 5M-dose launch inventory & manufacturing scale-up to 1M doses/month. Sub-$5 with high beta. News flow accelerating. | 7 | $3.40 | $3.49 | $3.61 | ▲ +2.65% |
| LONG ENGN Entered $1.82 | enGene Holdings Inc | Earnings before open Monday 9/14. Clinical-stage genetic medicine company (duodenal gene therapy for GI diseases). Penny stock biotech with earnings catalyst often creates volatility. Low float amplifies moves. Check premarket volume >200k for liquidity confirmation. Risk: biotech earnings often sell-the-news; use tight stop below premarket low. | 6 | $1.82 | $1.87 | $1.88 | ▲ +2.75% |
24-Hour Picks Entry: close of 2026-09-10 — Exit: close of 2026-09-14
| Ticker | Company | Rationale | Conf | Entry | Exit | Peak | Return |
|---|---|---|---|---|---|---|---|
| LONG UCO Entered $52.41 | ProShares Ultra Bloomberg Crude Oil | Oil fundamentals tightened by US‑Iran Hormuz disruptions; expect WTI to hold above $104.14 support and test $105.48 resistance tomorrow, boosting UCO. | 7 | $52.41 | $52.08 | $52.82 | ▼ -0.63% |
| SHORT GDX Entered $93.23 | VanEck Gold Miners ETF | Fed rate hike probability at 86% post‑CPI strengthening USD; expect gold to struggle near $4,300 support tomorrow, pressuring GDX. | 7 | $93.23 | $94.14 | $92.85 | ▼ -0.98% |
24-Hour Picks Entry: close of 2026-09-10 — Exit: close of 2026-09-14
| Ticker | Company | Rationale | Conf | Entry | Exit | Peak | Return |
|---|---|---|---|---|---|---|---|
| SHORT SOL-USD Confirmed +0.2% | Solana | Token unlock overhang (~$2B, ~2% FDV in 12 days) capping upside; price rejected at $100 psychological resistance for 3 sessions; 7d trend -4.4% with lower highs; holding above EMAs but MACD cooling and RSI ~56-60 neutral. Clear catalyst: unlock supply pressure + resistance rejection. Entry $98-99, target $92-96 (EMA20/50 cluster), stop $102 (above recent range high). | 6 | $98.69 | $103.26 | $98.63 | ▼ -4.63% |
| SHORT BTC-USD Confirmed +0.1% | Bitcoin | Rounding top on 4h confirmed; testing key $76K-$76.5K support (4h close below $76K = breakdown). 7d trend -4.1%; open interest heavy at $53B (+14% MoM) with shorts clustered $78K — funding compressing, flip negative on $76K test adds squeeze fuel but breakdown targets $75K-76.7K then $70K. Fed Sept 16 hike 90% prob (CME) = macro headwind. Recent long calls at support failed (BTC long -1.57% 9/11). Entry on 4h close <$76K, target $75K then $73K, stop $77.5K. | 5 | $76568.12 | $78761.07 | $76162.91 | ▼ -2.86% |